Dcr3 inhibit p53-dependent apoptosis in γ-irradiated lung cancer cells

International Journal of Radiation Biology

Volumn 86, Issue 9, 2010, Pages 780-790

  Sung, Hye Youn ^a   Wu, Hong Gyun ^a   Ahn, Jung Hyuck ^b   Park, Woong Yang ^a  

^a Seoul National University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

apoptosis; Dcr3; lung cancer; p53; radiosensitivity

Indexed keywords

CASPASE 8; DECOY RECEPTOR 3; MESSENGER RNA; PROTEIN P53; TNFRSF6B PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; GAMMA RADIATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG NEOPLASMS; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; TUMOR CELL LINE;

APOPTOSIS; CASPASE 8; CELL LINE, TUMOR; GAMMA RAYS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; RADIATION TOLERANCE; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956288055     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2010.484481     Document Type: Article

References (35)

1. Amundson SA, Do KT, Shahab S, Bittner M, Meltzer P, Trent J, Fornace AJ Jr. 2000. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiation Research 154(3):342-346.
2. Aravindan N, Madhusoodhanan R, Natarajan M, Herman TS. 2008. Alteration of apoptotic signaling molecules as a function of time after radiation in human neuroblastoma cells. Molecular and Cellular Biochemistry 310(1-2):167-179.
3. Ashkenazi A, Dixit VM. 1999. Apoptosis control by death and decoy receptors. Current Opinion in Cell Biology 11(2):255-260.
4. Bernhard EJ, Stanbridge EJ, Gupta S, Gupta AK, Soto D, Bakanauskas VJ, Cerniglia GJ, Muschel RJ, McKenna WG. 2000. Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines. Cancer Research 60(23):6597-6600.
5. Biard DS, Martin M, Rhun YL, Duthu A, Lefaix JL, May E, May P. 1994. Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Research 54(13):3361-3364.
6. Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. 1993. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research 53(16):3667-3669.
7. Chaudhry MA. 2008a. Analysis of gene expression in normal and cancer cells exposed to gamma-radiation. Journal of Biomedicine and Biotechnology 2008:541678.
8. Chaudhry MA. 2008b. Biomarkers for human radiation exposure. Journal of Biomedical Science 15(5):557-563.
9. Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-Ullrich R. 2003. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiation Research 159(3):283-300.
10. Dunne AL, Price ME, Mothersill C, McKeown SR, Robson T, Hirst DG. 2003. Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells. British Journal of Cancer 89(12):2277-2283.
11. Embree-Ku M, Venturini D, Boekelheide K. 2002. Fas is involved in the p53-dependent apoptotic response to ionizing radiation in mouse testis. Biology of Reproduction 66(5):1456-1461.
12. Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y, Hagiwara A, Mitsufuji S, Okazaki Y, Hayashizaki Y, Yamagishi H. 2004. Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. British Journal of Cancer 91(8):1543-1550.
13. Grace MB, McLeland CB, Blakely WF. 2002. Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry. International Journal of Radiation Biology 78(11):1011-1021.
14. Guo WF, Lin RX, Huang J, Zhou Z, Yang J, Guo GZ, Wang SQ. 2005. Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis. Radiation Research 164(1):27-35.
15. Hanna E, Shrieve DC, Ratanatharathorn V, Xia X, Breau R, Suen J, Li S. 2001. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Research 61(6):2376-2380.
16. Harima Y, Togashi A, Horikoshi K, Imamura M, Sougawa M, Sawada S, Tsunoda T, Nakamura Y, Katagiri T. 2004. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. International Journal of Radiation Oncology.Biology.Physics 60(1):237-248.
17. Hayashi S, Miura Y, Nishiyama T,Mitani M, Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S, Doita M. 2007. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Arthritis & Rheumatism 56(4):1067-1075.
18. Hsiao M, Tse V, Carmel J, Costanzi E, Strauss B, Haas M, Silverberg GD. 1997. Functional expression of human p21(WAF1/CIP1) gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity. Biochemical and Biophysical Research Communications 233(2):329-335.
19. Kelley SK, Ashkenazi A. 2004. Targeting death receptors in cancer with Apo2L/TRAIL. Current Opinion in Pharmacology 4(4):333-339.
20. Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y. 2002. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 4(4):295-303.
21. Lee JM, Bernstein A. 1993. p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences of the USA 90(12):5742-5746.
22. Liu X, Yue P, Khuri FR, Sun SY. 2005. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Cancer Research 65(20):9169-9175.
23. Maebayashi K, Mitsuhashi N, Takahashi T, Sakurai H, Niibe H. 1999. p53 mutation decreased radiosensitivity in rat yolk sac tumor cell lines. International Journal of Radiation Oncology. Biology. Physics 44(3):677-682.
24. Maecker HL, Koumenis C, Giaccia AJ. 2000. p53 promotes selection for Fas-mediated apoptotic resistance. Cancer Research 60(16):4638-4644.
25. Matsumura Y, Yamagishi N, Miyakoshi J, Imamura S, Takebe H. 1997. Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene. Cancer Letters 115(1):91-96.
26. Nix P, Cawkwell L, Patmore H, Greenman J, Stafford N. 2005. Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. British Journal of Cancer 92(12): 2185-2189.
27. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, Murayama S, Mori M. 2006. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. International Journal of Oncology 28(3):705-713.
28. Park WY, Hwang CI, Im CN, Kang MJ, Woo JH, Kim JH, Kim YS, Kim H, Kim KA, Yu H J, Lee SJ, Lee YS, Seo JS. 2002. Identification of radiation-specific responses from gene expression profile. Oncogene 21(55):8521-8528.
29. Park WY, Park JS, Cho KA, Kim DI, Ko YG, Seo JS, Park SC. 2000. Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. Journal of Biological Chemistry 275(27):20847-20852.
30. Riva C, Lavieille JP, Reyt E, Brambilla E, Lunardi J, Brambilla C. 1995. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. European Journal of Cancer: Part B -Oral Oncology 31B(6):384-391.
31. Sheard MA. 2001. Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis. International Journal of Cancer 96(4):213-220.
32. Sklar MD. 1988. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239(4840):645-647.
33. Slichenmyer WJ,NelsonWG, Slebos RJ, KastanMB. 1993. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research 53(18):4164-4168.
34. Toscano F, Fajoui ZE, Gay F, Lalaoui N, Parmentier B, Chayvialle JA, Scoazec JY, Micheau O, Abello J, Saurin JC. 2008. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells. Oncogene 27(30):4161-4171.
35. Viktorsson K, De Petris L, Lewensohn R. 2005. The role of p53 in treatment responses of lung cancer. Biochemical and Biophysical Research Communications 331(3):868-880.